Is Pliant Therapeutics Inc (NASDAQ: PLRX) Back In The Buying Zone?
Currently, there are 59.92M common shares owned by the public and among those 53.41M shares have been available to trade. The company’s stock has a 5-day price change of -5.14% and -27.14% over the past three months. PLRX shares are trading -40.86% year to date (YTD), with the 12-month market performance down to -51.89% lower. […]
